Yes, Medicaid covers buprenorphine in every state. Federal law makes coverage of all FDA-approved medications for opioid use disorder a mandatory Medicaid benefit, and buprenorphine, including brand names like Suboxone, Subutex, Sublocade, and Brixadi, falls squarely inside that requirement. About 47% of nonelderly adults with opioid use disorder are covered by Medicaid, making the program the single largest payer for this treatment in the country.
What varies from plan to plan is not whether buprenorphine is covered but how easily you can get it: prior authorization rules, dosage caps, and small copays can all sit between you and your prescription.
Why Coverage Is Required by Law
The SUPPORT for Patients and Communities Act, signed in 2018, added a mandatory Medicaid benefit for medication-assisted treatment of opioid use disorder. The statute is written broadly: it covers all drugs approved by the FDA and all biological products licensed to treat opioid use disorder, together with the counseling and behavioral therapy services that accompany them.1Office of the Law Revision Counsel. 42 U.S. Code 1396d – Definitions
CMS has interpreted that language to mean states must include every FDA-approved formulation of buprenorphine, methadone, and naltrexone, not just the ones a state would prefer to pay for.2Medicaid.gov. Mandatory Medicaid State Plan Coverage of Medication-Assisted Treatment
Which Formulations of Buprenorphine Medicaid Covers
Because the mandate reaches every FDA-approved formulation, your state Medicaid program should cover buprenorphine regardless of how it is delivered.
- Sublingual tablets and films that dissolve under the tongue. Brand names include Suboxone (buprenorphine combined with naloxone) and Subutex (buprenorphine alone). Generic versions are widely available and are often preferred on Medicaid formularies.
- Extended-release injections. Sublocade is a monthly injection given by a healthcare provider, and Brixadi comes as either a weekly or monthly injection.
Injectables are administered in a clinical setting rather than filled at a pharmacy. They carry a higher per-dose cost, so managed care plans are more likely to require prior authorization before approving them.
Prior Authorization and Dosage Caps
Federal law requires Medicaid to cover buprenorphine. It does not stop states or Medicaid managed care organizations from putting utilization controls in place. Prior authorization, preferred drug lists, and dosage limits are all common, and they add steps between you and your prescription rather than denying coverage outright.3MACPAC. Access to Medications for Opioid Use Disorder in Medicaid
The most common restriction is a daily dosage cap. About 73% of Medicaid managed care organizations cap oral buprenorphine at 24 milligrams per day. If your prescriber decides you need more, they will usually need to submit a prior authorization request documenting the medical necessity.3MACPAC. Access to Medications for Opioid Use Disorder in Medicaid
Timelines vary. Some plans process prior authorization requests within 24 hours, particularly for urgent situations; others take several days. If your plan requires prior authorization, ask your prescriber’s office to submit it right away. Delays are dangerous for someone in active withdrawal, and experienced providers know how to flag these requests as expedited.
What You’ll Pay
Many state Medicaid programs cover buprenorphine with no copay. Not all do. Recent data show roughly a third of state Medicaid fee-for-service programs required some form of copayment for buprenorphine. Where copays apply, the amounts are small. Federal law caps total Medicaid premiums and cost-sharing for all services at 5% of a household’s income, and prescription copays are typically only a few dollars.
If you are in a Medicaid managed care plan rather than fee-for-service, the copay structure may differ. Check your member handbook or call member services to confirm what you owe at the pharmacy.
Who Can Prescribe Buprenorphine Now
Access widened sharply in 2023. The Consolidated Appropriations Act of that year eliminated the old X-waiver requirement under DATA-2000, which had limited buprenorphine prescribing to a small pool of specially certified providers.4Substance Abuse and Mental Health Services Administration. Waiver Elimination (MAT Act)
Today, any practitioner with a DEA registration that includes Schedule III authority can prescribe buprenorphine for opioid use disorder. That covers physicians, nurse practitioners, and physician assistants. The one remaining hurdle is a one-time eight-hour training on treating substance use disorders, completed when practitioners apply for or renew their DEA registration.5Drug Enforcement Administration Diversion Control Division. Medication Assisted Treatment In practice, your primary care doctor may be able to prescribe buprenorphine without sending you to a specialist.
Telehealth Access
You do not necessarily need an in-person visit to start treatment. A permanent DEA rule that took effect on December 31, 2025 created a dedicated pathway for practitioners to prescribe buprenorphine for opioid use disorder through telemedicine without a prior in-person evaluation. The visit must use audio-visual technology (a video call, not just a phone call), and the rule sets specific documentation requirements.6Drug Enforcement Administration. DEA Extends Telemedicine Flexibilities to Ensure Continued Access to Care
Broader COVID-era telemedicine flexibilities for all controlled substances have been separately extended through December 31, 2026. Under those temporary rules, DEA-registered practitioners can prescribe Schedule II through V controlled substances by telemedicine without an in-person exam, provided the prescription meets all other federal and state requirements.6Drug Enforcement Administration. DEA Extends Telemedicine Flexibilities to Ensure Continued Access to Care For buprenorphine specifically, the permanent rule keeps telehealth access in place even after those temporary flexibilities expire.
This matters most for enrollees in rural areas and underserved communities where local prescribers are scarce. If your Medicaid plan covers telehealth visits, you can get evaluated, prescribed, and started on treatment without traveling.
Finding a Provider Who Takes Medicaid
Your Medicaid plan’s provider directory is often the fastest place to start. Call the member services number on your Medicaid card and ask specifically for providers who prescribe buprenorphine and accept your plan. In a managed care plan, this also protects you from out-of-network billing.
SAMHSA also runs a buprenorphine treatment locator, and FindTreatment.gov links to it.7FindTreatment.gov. FindTreatment.gov One caveat: the locator was built around the old X-waiver system and lists only practitioners who previously held waivers and consented to share their information. Since any DEA-registered practitioner can now prescribe buprenorphine, the locator no longer captures the full pool of available prescribers.8Substance Abuse and Mental Health Services Administration. Buprenorphine Treatment Locator for Opioid Dependency
Once you find a provider, the process is straightforward. They will assess whether buprenorphine is appropriate, write a prescription if it is, and you fill it at a Medicaid-participating pharmacy. Sublocade and other injectables are administered at the provider’s office rather than at a pharmacy. Follow-up visits, counseling, and ongoing monitoring are part of the treatment and are also covered under Medicaid.
If Your Plan Denies Coverage
If your Medicaid plan denies a prior authorization request or refuses to cover a specific formulation, you can appeal. The first step is usually an internal appeal through your managed care organization. Your prescriber’s office can often handle this by submitting extra clinical documentation showing why the specific medication or dosage is medically necessary.
Beyond the internal appeal, every Medicaid enrollee has the right to request a fair hearing through the state Medicaid agency. That is an independent review, separate from your plan’s internal process. Contact your state Medicaid office to learn how to request one. Given the federal mandate to cover every FDA-approved medication for opioid use disorder, a denial based on the type of buprenorphine formulation rather than a clinical concern is worth pushing back on.
A Note on Medicaid Eligibility
Coverage of buprenorphine only helps if you qualify for Medicaid in the first place. In states that expanded Medicaid under the Affordable Care Act, adults with household incomes up to 138% of the federal poverty level qualify even if they are not pregnant, disabled, or caring for dependent children. In states that did not expand, eligibility is more restrictive and often limited to pregnant women, parents of minor children, or people with qualifying disabilities, and adults without children may not qualify regardless of income. If you are not sure where you stand, contact your state Medicaid agency or check healthcare.gov.